FIT More Cost-Effective Than Blood-Based MDx, Colonoscopies for CRC

Screening, Study Finds

· Media Resources

NEW YORK – A recent study published in Frontiers in Oncology analyzing six modalities for colorectal cancer screening,including fecal immunochemical testing (FIT), blood- and stool-based molecular tests, and colonoscopies, has found that FIT is by far the most cost-effective.

Previous
Cookie Use
We use cookies to improve browsing experience, security, and data collection. By accepting, you agree to the use of cookies for advertising and analytics. You can change your cookie settings at any time. Learn More
Accept all
Settings
Decline All
Cookie Settings
These cookies enable core functionality such as security, network management, and accessibility. These cookies can’t be switched off.
These cookies help us better understand how visitors interact with our website and help us discover errors.
These cookies allow the website to remember choices you've made to provide enhanced functionality and personalization.
Save